Delivery Order SPE2DB24D1205-SPE2DB25FCWUB
Award Date
5/14/25
Potential Completion Date
6/5/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ZOLADEX 10.8 MG IMPLANT SYRNS medical supplies. The contract has a total ceiling value of $11,157.00 and a performance period through May 6, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,677.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication. The award was made on December 23, 2022, with a completion date of January 18, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a potential value of $3,509.16 and a completion date of January 31, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,735.50, is a Firm Fixed Price Delivery Order to provide ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product, with a ceiling value of $5,578.50. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide the ZOLADEX 10.8 MG IMPLANT SYRNS medication. The order has a ceiling value of $9,011.22 and a performance period through April 24, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,314.00, is for the supply of the medication ZOLADEX 10.8 MG IMPLANT SYRNS. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,303.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 10, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,754.58 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of March 15, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,610,200 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a completion date of February 29, 2024 and a potential value of $8,772.80. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...